KEAP1 and lung carcinoma: In KEAP1-deficient lung cancer, RSPO3, the ligand that activates Wnt signaling, is upregulated due to the Keap1 deficiency and, along with its receptor LGR4, mediates cell migration and metastasis in an IQGAP1-dependent manner [145].